Here are three highlights:
1. Trump’s rhetoric impacted many companies’ stock prices. The ARCA pharmaceutical index closed Jan. 11, 2017, trading down 1.7 percent.
2. Brad Loncar, manager of the Loncar Cancer Immunotherapy Index, told Reuters that whenever someone high profile takes aim at an industry, it could impact investments in various products. However, Mr. Loncar noted drug pricing is a complicated issue as “there’s not going to be clarity of drug pricing reform anytime soon.”
3. Trump’s language is not unique to the pharmaceutical industry, with the president-elect also saying Amazon was “getting away with murder” in May 2016 over the company’s taxing practices.
More articles on quality & infection control:
6 key points on the global medical tapes market
WHO: Smoking costs world $1T annually: 3 quick notes
Trump: No decision made for head of vaccine safety panel, but providers still voice opposition
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.